Physician profile
Jonathan D Primack
NPI 1518937457
$1,305.51
in general payments reported to CMS, 2019-2025
16 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $48.88 · 2021: $89.16 · 2022: $237 · 2023: $283 · 2024: $212 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $393.00 | 2019-2025 | Clareon, Centurion, Unity |
| Abbvie INC. | $339.26 | 2022-2025 | |
| Rxsight INC | $156.48 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $105.02 | 2019-2025 | Tecnis Iol, Veritas Vision System, Catalys System |
| Dompe US, INC. | $78.84 | 2021-2025 | Oxervate |
| Oyster Point Pharma, INC. | $49.61 | 2023-2025 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $28.13 | 2023 | Eylea Hd |
| Ani Pharmaceuticals, INC. | $25.94 | 2025 | Iluvien |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rayner Intraocular Lenses Limited | $19.15 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Sun Pharmaceutical Industries INC. | $18.13 | 2024 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Amgen INC. | $17.14 | 2025 | Tepezza |
| Alcon Research LLC | $14.38 | 2019 | |
| Ocular Therapeutix, INC. | $12.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Primack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.